PolyPid announced the appointment of Nurit Tweezer-Zaks, M.D., M.B.A, to its Board of Directors, effective November 6, 2023, following the retirement of Anat Tsour Segal. Dr. Tweezer-Zaks currently serves as CEO of MediCane Health, a fully-integrated global medical cannabis company.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PYPD:
- PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results
- PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023
- PolyPid price target raised to $10 from $2.50 at Barclays
- PolyPid initiated with a Buy at H.C. Wainwright
- PolyPid regains compliance with Nasdaq minimum closing bid price rule
